210 related articles for article (PubMed ID: 1982059)
1. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
[TBL] [Abstract][Full Text] [Related]
2. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Norris RJ
Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
[TBL] [Abstract][Full Text] [Related]
4. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
van Zyl AI; Jennings AA; Bateman ED; Opie LH
Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
[TBL] [Abstract][Full Text] [Related]
5. Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.
Pujet JC; Dubreuil C; Fleury B; Provendier O; Abella ML
Eur Respir J; 1992 Feb; 5(2):196-200. PubMed ID: 1348481
[TBL] [Abstract][Full Text] [Related]
6. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
[TBL] [Abstract][Full Text] [Related]
7. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
Fogari R; Zoppi A; Tettamanti F; Malamani G; Pasotti C
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
[TBL] [Abstract][Full Text] [Related]
8. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
Silke B; Guy S; Riddell JG
J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Fogari R; Zoppi A; Corradi L; Preti P; Mugellini A; Lusardi P
J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
[TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of celiprolol in hypertensive patients with chronic obstructive lung disease].
Chahuán M; Corradi L; Román O; Bravo C
Rev Med Chil; 2000 Jan; 128(1):59-63. PubMed ID: 10883523
[TBL] [Abstract][Full Text] [Related]
11. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
[TBL] [Abstract][Full Text] [Related]
12. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
Matthys H; Doshan HD; Rühle KH; Applin WJ; Braig H; Pohl M
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S40-2. PubMed ID: 2427851
[TBL] [Abstract][Full Text] [Related]
13. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the influence of celiprolol, metoprolol and atenolol on pulmonary ventilation in patients with asthma].
Szmidt M; Minc P; Wasiak W
Pneumonol Alergol Pol; 1999; 67(9-10):452-61. PubMed ID: 10808389
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
[TBL] [Abstract][Full Text] [Related]
16. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
Milne RJ; Buckley MM
Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
[TBL] [Abstract][Full Text] [Related]
17. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
18. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
Smith RD; Barrett JA; Wolf PS; Pruss TP
Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
[No Abstract] [Full Text] [Related]
19. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
20. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
Schindl R; Würtz J; Hoffmann H
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S99-101. PubMed ID: 2427862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
